Immunoproteomic identification of bovine pericardium xenoantigens

Biomaterials

Volumn 29, Issue 26, 2008, Pages 3514-3520

  Griffiths, Leigh G ^a   Choe, Leila H ^c   Reardon, Kenneth F ^b   Dow, Steven W ^a   Christopher Orton, E ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

^b Department of Chemical and Biological Engineering and School of Biomedical Engineering   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

Author keywords

Heart valve; Immunoproteomics; Scaffold; Tissue engineering; Xenoantigens

Indexed keywords

ALDEHYDES; ANTIGENS; BIOLOGICAL MATERIALS; BIOMOLECULES; BODY FLUIDS; COLLOIDS; COMPUTER NETWORKS; ELECTROPHORESIS; EXTRACTION; GELATION; GELS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; KETONES; LIPIDS; MASS SPECTROMETRY; NETWORK PROTOCOLS; OFFSHORE OIL WELL PRODUCTION; PAINTING; PROTEINS; SOLVENT EXTRACTION; TECHNOLOGY; TISSUE CULTURE; TISSUE ENGINEERING; TWO DIMENSIONAL;

BIOPROSTHESES; BIOPROSTHETIC HEART VALVES; BOVINE PERICARDIUM (BP); FULLSCOPE (CO); GEL ELECTROPHORESIS (GE); GENERAL (CO); GLUTARALDEHYDE (GTA); HUMORAL IMMUNE RESPONSE; IMMUNE RESPONSES; MATRIX PROTEIN (P17); POST EXPOSURE; PROTEIN EXTRACTION; PROTEIN FRACTIONS; PUTATIVE PROTEINS; STAINING INTENSITY; TANDEM MASS SPECTROMETRY (MS/MS); TISSUE ENGINEERING APPLICATIONS; TWO STAGES; TWO-DIMENSIONAL (2D); WESTERN BLOTTING; XENOTRANSPLANTATION;

TISSUE;

IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERICARDIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RABBIT; TANDEM MASS SPECTROMETRY; TISSUE ENGINEERING; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANTIGENS, HETEROPHILE; BIOCOMPATIBLE MATERIALS; CATTLE; MOLECULAR SEQUENCE DATA; PERICARDIUM; PROTEOME; RABBITS;

BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 46149122950     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.05.006     Document Type: Article

References (70)

1. Human P., and Zilla P. Inflammatory and immune processes: the neglected villain of bioprosthetic degeneration?. J Long Term Eff Med Implants 11 3-4 (2001) 199-220
2. Dahm M., Lyman W.D., Schwell A.B., Factor S.M., and Frater R.W. Immunogenicity of glutaraldehyde-tanned bovine pericardium. J Thorac Cardiovasc Surg 99 6 (1990 Jun) 1082-1090
3. Dahm M., Husmann M., Eckhard M., Prufer D., Groh E., and Oelert H. Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves. Ann Thorac Surg 60 Suppl. 2 (1995 Aug) S348-S352
4. Human P., and Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 71 Suppl. 5 (2001 May) S385-S388
5. Mirzaie M., Meyer T., Saalmuller A., and Dalichau H. Influence of glutaraldehyde fixation on the detection of SLA-I and II antigens and calcification tendency in porcine cardiac tissue. Scand Cardiovasc J 34 6 (2000 Dec) 589-592
6. Salgaller M.L., and Bajpai P.K. Immunogenicity of glutaraldehyde-treated bovine pericardial tissue xenografts in rabbits. J Biomed Mater Res 19 1 (1985 Jan) 1-12
7. Manji R.A., Zhu L.F., Nijjar N.K., Rayner D.C., Korbutt G.S., Churchill T.A., et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 114 4 (2006 Jul 25) 318-327
8. Goncalves A.C., Griffiths L.G., Anthony R.V., and Orton E.C. Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens. J Heart Valve Dis 14 2 (2005 Mar) 212-217
9. Mendelson K., and Schoen F.J. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 34 12 (2006 Dec) 1799-1819
10. Neuenschwander S., and Hoerstrup S.P. Heart valve tissue engineering. Transpl Immunol 12 3-4 (2004 Apr) 359-365
11. Schmidt C.E., and Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21 22 (2000 Nov) 2215-2231
12. Schmidt D., Stock U.A., and Hoerstrup S.P. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci 362 (2007) 1505-1512
13. Xiao Z., Zhang E., Li Y., Chen H., and Lai Y. Immunogenicity of acellular bovine pericardium in vivo. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 22 6 (2005 Dec) 1203-1205
14. Steinhoff G., Stock U., Karim N., Mertsching H., Timke A., Meliss R.R., et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102 19 Suppl. 3 (2000 Nov 7) III50-III55
15. Cebotari S., Mertsching H., Kallenbach K., Kostin S., Repin O., Batrinac A., et al. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106 12 Suppl. 1 (2002 Sep 24) I63-I68
16. Bertipaglia B., Ortolani F., Petrelli L., Gerosa G., Spina M., Pauletto P., et al. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thorac Surg 75 4 (2003 Apr) 1274-1282
17. Schenke-Layland K., Opitz F., Gross M., Doring C., Halbhuber K.J., Schirrmeister F., et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals - an in vitro study. Cardiovasc Res 60 3 (2003 Dec 1) 497-509
18. Elkins R.C., Dawson P.E., Goldstein S., Walsh S.P., and Black K.S. Decellularized human valve allografts. Ann Thorac Surg 71 Suppl. 5 (2001 May) S428-S432
19. O'Brien M.F., Goldstein S., Walsh S., Black K.S., Elkins R., and Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 11 4 Suppl. 1 (1999 Oct) 194-200
20. Goldstein S., Clarke D.R., Walsh S.P., Black K.S., and O'Brien M.F. Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg 70 6 (2000 Dec) 1962-1969
21. Booth C., Korossis S.A., Wilcox H.E., Watterson K.G., Kearney J.N., Fisher J., et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 11 4 (2002 Jul) 457-462
22. Korossis S.A., Booth C., Wilcox H.E., Watterson K.G., Kearney J.N., Fisher J., et al. Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J Heart Valve Dis 11 4 (2002 Jul) 463-471
23. Bader A., Schilling T., Teebken O.E., Brandes G., Herden T., Steinhoff G., et al. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 14 3 (1998 Sep) 279-284
24. Taylor P.M. Biological matrices and bionanotechnology. Philos Trans R Soc Lond B Biol Sci 362 1484 (2007 Aug 29) 1313-1320
25. Fang N.T., Xie S.Z., Wang S.M., Gao H.Y., Wu C.G., and Pan L.F. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin Med J (Engl) 120 8 (2007 Apr 20) 696-702
26. Zhao D.E., Li R.B., Liu W.Y., Wang G., Yu S.Q., Zhang C.W., et al. Tissue-engineered heart valve on acellular aortic valve scaffold: in-vivo study. Asian Cardiovasc Thorac Ann 11 2 (2003 Jun) 153-156
27. Kasimir M.T., Rieder E., Seebacher G., Nigisch A., Dekan B., Wolner E., et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis 15 2 (2006 Mar) 278-286 [discussion 286]
28. Simon P., Kasimir M.T., Seebacher G., Weigel G., Ullrich R., Salzer-Muhar U., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23 6 (2003 Jun) 1002-1006
29. Vesely I., Noseworthy R., and Pringle G. The hybrid xenograft/autograft bioprosthetic heart valve: in vivo evaluation of tissue extraction. Ann Thorac Surg 60 Suppl. 2 (1995 Aug) S359-S364
30. Ueda Y., Torrianni M.W., Coppin C.M., Iwai S., Sawa Y., and Matsuda H. Antigen clearing from porcine heart valves with preservation of structural integrity. Int J Artif Organs 29 8 (2006 Aug) 781-789
31. Kasimir M.T., Rieder E., Seebacher G., Wolner E., Weigel G., and Simon P. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng 11 7-8 (2005 Jul-Aug) 1274-1280
32. National Research Council, and Institute of Laboratory Animal Resources Commission on Life Sciences. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
33. Hansson S.F., Puchades M., Blennow K., Sjogren M., and Davidsson P. Validation of a prefractionation method followed by two-dimensional electrophoresis - applied to cerebrospinal fluid proteins from frontotemporal dementia patients. Proteome Sci 2 1 (2004 Nov 18) 7
34. Hopfer U., Hopfer H., Jablonski K., Stahl R.A., and Wolf G. The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). J Biol Chem 281 13 (2006 Mar 31) 8645-8655
35. Lacerda C.M., Choe L.H., and Reardon K.F. Metaproteomic analysis of a bacterial community response to cadmium exposure. J Proteome Res 6 3 (2007 Mar) 1145-1152
36. Yan J.X., Wait R., Berkelman T., Harry R.A., Westbrook J.A., Wheeler C.H., et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21 17 (2000 Nov) 3666-3672
37. Rabilloud T., and Charmont S. In: Rabilloud T. (Ed). Proteome research: two-dimensional gel electrophoresis and identification methods (2000), Springer, Berlin, New York
38. Choe L.H., Aggarwal K., Franck Z., and Lee K.H. A comparison of the consistency of proteome quantitation using two-dimensional electrophoresis and shotgun isobaric tagging in Escherichia coli cells. Electrophoresis 26 12 (2005 Jun) 2437-2449
39. Pedersen S.K., Harry J.L., Sebastian L., Baker J., Traini M.D., McCarthy J.T., et al. Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins. J Proteome Res 2 3 (2003 May-Jun) 303-311
40. Sprenger J., Fink J.L., and Teasdale R.D. Evaluation and comparison of mammalian subcellular localization prediction methods. BMC Bioinformatics 7 Suppl. 5 (2006) S3
41. Tusnady G.E., and Simon I. Principles governing amino acid composition of integral membrane proteins: application to topology prediction. J Mol Biol 283 2 (1998 Oct 23) 489-506
42. Mitchison N.A. T-cell-B-cell cooperation. Nat Rev Immunol 4 4 (2004 Apr) 308-312
43. McHeyzer-Williams L.J., and McHeyzer-Williams M.G. Antigen-specific memory B cell development. Annu Rev Immunol 23 (2005) 487-513
44. Brichory F.M., Misek D.E., Yim A.M., Krause M.C., Giordano T.J., Beer D.G., et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 98 17 (2001 Aug 14) 9824-9829
45. Fujita Y., Nakanishi T., Hiramatsu M., Mabuchi H., Miyamoto Y., Miyamoto A., et al. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res 12 21 (2006 Nov 1) 6415-6420
46. Chang J.W., Lee S.H., Jeong J.Y., Chae H.Z., Kim Y.C., Park Z.Y., et al. Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett 579 13 (2005 May 23) 2873-2877
47. Xiang Y., Sekine T., Nakamura H., Imajoh-Ohmi S., Fukuda H., Nishioka K., et al. Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum 50 5 (2004 May) 1511-1521
48. He P., Naka T., Serada S., Fujimoto M., Tanaka T., Hashimoto S., et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 98 8 (2007 Aug) 1234-1240
49. Mini R., Bernardini G., Salzano A.M., Renzone G., Scaloni A., Figura N., et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci 833 1 (2006 Mar 20) 63-79
50. Krah A., and Jungblut P.R. Immunoproteomics. Methods Mol Med 94 (2004) 19-32
51. Oshima M. Species-specific antigenic reactive regions in alpha and beta chains of human hemoglobin. Igaku Kenkyu 52 6 (1982 Dec) 313-327
52. Beretta B., Conti A., Fiocchi A., Gaiaschi A., Galli C.L., Giuffrida M.G., et al. Antigenic determinants of bovine serum albumin. Int Arch Allergy Immunol 126 3 (2001 Nov) 188-195
53. Terrier B., Degand N., Guilpain P., Servettaz A., Guillevin L., and Mouthon L. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev 6 3 (2007 Jan) 176-182
54. Bogdanos D.P., Gilbert D., Bianchi I., Leoni S., Mitry R.R., Ma Y., et al. Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis 1 1 (2004 Nov 19) 4
55. Aslan H., Pay S., Gok F., Baykal Y., Yilmaz M.I., Sengul A., et al. Antiannexin V autoantibody in thrombophilic Behcet's disease. Rheumatol Int 24 2 (2004 Mar) 77-79
56. Rodriguez-Garcia M.I., Fernandez J.A., Rodriguez A., Fernandez M.P., Gutierrez C., and Torre-Alonso J.C. Annexin V autoantibodies in rheumatoid arthritis. Ann Rheum Dis 55 12 (1996 Dec) 895-900
57. Zeng X., Liao A.J., Tang H.L., Yi L., Xie N., and Su Q. Screening human gastric carcinoma-associated antigens by serologic proteome analysis. Ai Zheng 26 10 (2007 Oct) 1080-1084
58. Karasawa R., Ozaki S., Nishioka K., and Kato T. Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases. Microbiol Immunol 49 1 (2005) 57-65
59. Iwata Y., Ogawa F., Komura K., Muroi E., Hara T., Shimizu K., et al. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress. Rheumatology (Oxford) 46 5 (2007 May) 790-795
60. Fernandez B., Kampmann A., Pipp F., Zimmermann R., and Schaper W. Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Mol Cell Biochem 246 1-2 (2003 Apr) 3-11
61. Ge G., Seo N.S., Liang X., Hopkins D.R., Hook M., and Greenspan D.S. Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J Biol Chem 279 40 (2004 Oct 1) 41626-41633
62. Gumperz J.E. The ins and outs of CD1 molecules: bringing lipids under immunological surveillance. Traffic 7 1 (2006 Jan) 2-13
63. Bricard G., and Porcelli S.A. Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity. Cell Mol Life Sci 64 14 (2007 Jul) 1824-1840
64. Ezzelarab M., Ayares D., and Cooper D.K. Carbohydrates in xenotransplantation. Immunol Cell Biol 83 4 (2005 Aug) 396-404
65. Kearns-Jonker M., Barteneva N., Mencel R., Hussain N., Shulkin I., Xu A., et al. Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens. BMC Immunol 8 (2007) 3
66. van Duivenvoorde L.M., Louis-Plence P., Apparailly F., van der Voort E.I., Huizinga T.W., Jorgensen C., et al. Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. Arthritis Rheum 50 10 (2004 Oct) 3354-3364
67. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 13 5 (2007 May) 567-569
68. Bierczynska-Krzysik A., Kang S.U., Silberrring J., and Lubec G. Mass spectrometrical identification of brain proteins including highly insoluble and transmembrane proteins. Neurochem Int 49 3 (2006 Aug) 245-255
69. Oh-Ishi M., and Maeda T. Disease proteomics of high-molecular-mass proteins by two-dimensional gel electrophoresis with agarose gels in the first dimension (Agarose 2-DE). J Chromatogr B Analyt Technol Biomed Life Sci 849 1-2 (2007 Apr 15) 211-222
70. Hess J.L., Blazer L., Romer T., Faber L., Buller R.M., and Boyle M.D. Immunoproteomics. J Chromatogr B Analyt Technol Biomed Life Sci 815 1-2 (2005 Feb 5) 65-75